Skip to main content

Arrowstreet Capital, Limited Partnership

Source: SEC Form 13F · as of Mar 2026

Arrowstreet Capital, Limited Partnership holds 39 biotech & pharma companies tracked by BioSniper, totaling $1.30B in value as of Mar 2026 (SEC Form 13F).

Companies held

39

Total value held

$1.30B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Incyte Corp. (INCY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
INCYIncyte Corp.2,830,799$266.4M
EXELEXELIXIS, INC.4,834,625$207.4M
GMABGenmab A/S4,975,324$133.5M
REGNREGENERON PHARMACEUTICALS, INC.171,571$132.6M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,621,397$89.5M
IONSIONIS PHARMACEUTICALS INC737,859$55.4M
INVAInnoviva, Inc.1,887,570$44.0M
ANIPANI PHARMACEUTICALS INC564,360$43.4M
KNSAKiniksa Pharmaceuticals International, plc892,666$43.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.587,125$36.8M
ACADACADIA PHARMACEUTICALS INC1,569,491$34.9M
ONCBeOne Medicines Ltd.110,586$32.8M
ADPTAdaptive Biotechnologies Corp1,995,202$27.7M
ANABANAPTYSBIO, INC492,120$27.3M
GRFSGrifols S.A.2,723,385$21.8M
ZYMEZymeworks Inc.743,898$18.6M
NTLAIntellia Therapeutics, Inc.1,397,243$17.9M
AGIOAGIOS PHARMACEUTICALS, INC.250,461$8.5M
SIGASIGA TECHNOLOGIES INC1,525,960$8.2M
PTCTPTC THERAPEUTICS, INC.111,632$7.6M
KROSKeros Therapeutics, Inc.590,249$6.5M
NUVBNuvation Bio Inc.1,439,357$6.2M
SNYSanofi84,435$4.1M
ROIVRoivant Sciences Ltd.136,887$3.8M
PBYIPUMA BIOTECHNOLOGY, INC.538,155$3.4M
LGNDLigand Pharmaceuticals Incorporated14,564$2.9M
BDTXBlack Diamond Therapeutics, Inc.834,570$1.8M
UPBUpstream Bio, Inc.185,087$1.7M
BIOABioAge Labs, Inc.87,881$1.5M
PGENPRECIGEN, INC.395,695$1.5M
RDYDR REDDYS LABORATORIES LTD102,643$1.4M
MLTXMoonLake Immunotherapeutics70,140$1.3M
TEVATeva Pharmaceutical Industries Limited38,900$1.2M
ACIUAC Immune SA405,658$1.1M
ASMBASSEMBLY BIOSCIENCES, INC.39,446$1.1M
XERSXeris Biopharma Holdings, Inc.133,760$776K
VRDNViridian Therapeutics, Inc.\DE23,279$455K
SUPNSUPERNUS PHARMACEUTICALS, INC.7,595$393K
DAWNDay One Biopharmaceuticals, Inc.15,294$328K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.